This paper presents the 12th update of the human obesity gene map, which incorporates
published results up to the end of October 2005. Evidence from single‐gene mutation …

Vasoactive intestinal peptide (VIP) and the pituitary adenylate cyclase activating
polypeptides (PACAPs) share 68% identity at the amino acid level and belong to the …

Migraine is a widespread and debilitating neurological condition affecting more than a
billion people worldwide. Thus, more effective migraine therapies are highly needed. In the …

There are several therapeutic approaches in type 2 diabetes mellitus (T2DM). When diet
and exercise fail to control hyperglycemia, patients are forced to start therapy with …

Pituitary adenylate-cyclase-activating polypeptide (PACAP) is a 27-or 38-amino acid
neuropeptide, which belongs to the vasoactive intestinal polypeptide (VIP)/glucagon …

This paper presents the eleventh update of the human obesity gene map, which
incorporates published results up to the end of October 2004. Evidence from single‐gene …

Dipeptidyl peptidase IV (DP-IV) is a cell surface serine dipeptidase that is involved in the
regulation of the incretin hormones, glucagon-like peptide (GLP-1) and glucose-dependent …

The hypothalamic control of hepatic glucose production is an evident aspect of energy
homeostasis. In addition to the control of glucose metabolism by the circadian timing system …

To examine the distributions of VIP/PACAP receptors (VPAC1, VPAC2, and PAC1 receptors)
in the brain and to identify the cell types that express these receptors, we performed …

Pituitary adenylate cyclase activating polypeptide (PACAP) was first isolated from
hypothalamic extracts on the basis of its ability to stimulate cAMP formation in pituitary cells …